(Q42271998)

19 October 2017

Six-year pilot study on nucleic acid testing for blood donations in China (English)

1 reference

19 October 2017

Xianlin Ye

1

1 reference

19 October 2017

Baocheng Yang

2

1 reference

19 October 2017

Weigang Zhu

3

1 reference

19 October 2017

Xin Zheng

4

1 reference

19 October 2017

Peng Du

5

1 reference

19 October 2017

Jingfeng Zeng

6

1 reference

19 October 2017

Chengyao Li

7

1 reference

19 October 2017

26 August 2013

1 reference

Transfusion and Apheresis Science

19 October 2017

1 reference

19 October 2017

49

1 reference

19 October 2017

2

1 reference

19 October 2017

318-322

1 reference

Occult hepatitis B virus infection: implications in transfusion

19 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

Impact of nucleic acid amplification technology (NAT) in Italy in the three years following implementation (2001-2003).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

Characterization of occult hepatitis B virus infection from blood donors in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

Molecular characterization of occult hepatitis B virus in genotype E-infected subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

Nucleic acid testing to detect HBV infection in blood donors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

Nucleic acid testing (NAT) in high prevalence-low resource settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

Molecular characteristics of occult hepatitis B virus from blood donors in southeast China.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

Occult hepatitis B virus infection in Thai blood donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

Prevalence and prevalence trends of transfusion transmissible infections among blood donors at four Chinese regional blood centers between 2000 and 2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2013.08.005

10.1016/J.TRANSCI.2013.08.005

7 January 2021

Identifiers

DOI

1 reference

19 October 2017

1 reference